141 related articles for article (PubMed ID: 301159)
1. The substructure of antihemophilic factor (AHF, factor VIII): some clearing of the fog.
Ratnoff OD
J Lab Clin Med; 1977 Jun; 89(6):1159-62. PubMed ID: 301159
[No Abstract] [Full Text] [Related]
2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
3. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
4. [Hemophilias with major deficiency in antihemophilic factor. Von Willebrand's disease. Circulating anti-AHG anti-AHG anticoagulants].
Guimbretére J
Anesth Analg (Paris); 1975; 32(4):577-64. PubMed ID: 1084106
[No Abstract] [Full Text] [Related]
5. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
Bennett B; Forman WB; Ratnoff OD
J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
[TBL] [Abstract][Full Text] [Related]
6. The factor VIII complex: structure and function.
Hoyer LW
Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
[TBL] [Abstract][Full Text] [Related]
7. [The factor VIII complex: hemophilia A and von Willebrand disease (author's transl)].
Tobelem G; Rothschild C
Ann Pediatr (Paris); 1982 Feb; 29(2):95-9. PubMed ID: 6800297
[No Abstract] [Full Text] [Related]
8. [Molecular defect in hemophilia and von Willebrand's disease (author's transl)].
Fukui H
Rinsho Byori; 1976 Apr; 24(4):274-8. PubMed ID: 1084430
[No Abstract] [Full Text] [Related]
9. Editorial: Factor VIII, haemophilia and von Willebrand's disease.
S Afr Med J; 1974 Sep; 48(44):1853-4. PubMed ID: 4547189
[No Abstract] [Full Text] [Related]
10. Immunologic evidence that the antihemophilic factor (factor VIII)-like material in hemophilic plasma possesses a nonfunctional low molecular weight subcomponent.
Poon MC; Ratnoff OD
Blood; 1977 Sep; 50(3):367-76. PubMed ID: 301759
[No Abstract] [Full Text] [Related]
11. [Studies on human factor VIII (antihemophilic factor). I. Purification and properties of factor VIII (author's transl)].
Niiya K
Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):534-42. PubMed ID: 308760
[No Abstract] [Full Text] [Related]
12. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
Bennett B
Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
[No Abstract] [Full Text] [Related]
13. Antihaemophilic-factor-like protein in haemophilia.
Ekert H; Helliger H; Muntz RH
Med J Aust; 1973 Aug; 2(5):210-2. PubMed ID: 4542740
[No Abstract] [Full Text] [Related]
14. Study of congenital VIII complex deficiency syndrome: use of enzyme conjugated antibody.
Han P; Teo SH; Wong HB
J Singapore Paediatr Soc; 1987; 29(1):44-7. PubMed ID: 3121916
[No Abstract] [Full Text] [Related]
15. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Chediak J; Peake I; Bloom A
Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
[TBL] [Abstract][Full Text] [Related]
16. Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology.
Edgington TS
West J Med; 1975 May; 122(5):423-4. PubMed ID: 1079389
[No Abstract] [Full Text] [Related]
17. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
Uszyński L
Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
[No Abstract] [Full Text] [Related]
18. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
Yorde LD; Yorde DE; Sasse EA; Hussey CV
Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
[TBL] [Abstract][Full Text] [Related]
19. [Activation of antihemophilic globulin A (factor VIII). 1. Activation by ampholine].
Liebe S; Thierbach B
Z Gesamte Inn Med; 1982 Feb; 37(4):105-10. PubMed ID: 6805143
[TBL] [Abstract][Full Text] [Related]
20. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
Brinkhous KM
Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
